Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Reliable Biopharmaceutical Corporation Announces Facility Expansion for High Purity Ingredients

April 22, 2013

Reliable Biopharmaceutical Corporation (RBC) announced today that it has invested several million dollars into its High Purity production suites. These investments will nearly triple the production capacity in its High Purity Ingredients (HPI) line.

St. Louis, Missouri (PRWEB) April 22, 2013

Reliable Biopharmaceutical Corporation (RBC) announced today that it has invested several million dollars into its High Purity production suites. These investments will nearly triple the production capacity in its High Purity Ingredients (HPI) line.

RBC currently produces USP/EP Urea, and detergents including Sodium Dodecyl sulfate (SDS) and Lithium Dodecyl sulfate(LDS) in its High Purity Line. The capacity was needed to expand the product line to include a full line of fully validated biological buffers.

Lance Kunkel, Vice President Operations at Reliable Biopharmaceutical Corporation said, “It is always a great opportunity to be a part of growing business. The customers´ demand for our products required us to expand the facility in order to continue to meet their growing needs.”

David Feldker, President and CEO, Reliable Biopharmaceutical Corporation commented, “This expansion will provide the additional capacity necessary to introduce our products to new customers, so they too can experience the superior quality and service provided by RBC.”

About Reliable Biopharmaceutical Corporation

Founded in 1968, RBC is an integrated developer and manufacturer of Active Pharmaceutical Ingredients (APIs) and High Purity Ingredients (HPIs) for pharmaceuticals and biologics. RBC has established a strong position as a leading developer and manufacturer of complex generic injectable APIs. The company has 19 DMFs that have been accepted by Regulatory Agencies and has 19 more in various stages of development. RBC’s products are the active ingredients for leading generic injectable drugs that treat cancer, heart disease, hypertension, anxiety and other serious and life threatening illnesses. RBC also manufactures critical processing aids for the pharmaceutical industry and currently supplies these products to many of the world’s leading pharmaceutical and biotechnology companies.

For more information, contact:

Reliable Biopharmaceutical Corporation

James Wickenhauser, Vice President Sales and Marketing

(314) 429-7700

1945 Walton Road

St. Louis, Mo 63114

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/4/prweb10652007.htm


Source: prweb